How have AFFY shares performed in 2024?

Affymax's stock was trading at $0.0006 at the beginning of the year. Since then, AFFY stock has increased by 16.7% and is now trading at $0.0007. View the best growth stocks for 2024 here .

What other stocks do shareholders of Affymax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Affymax investors own include Golden Peak Minerals Inc.. (GRM) , (MCPIQ) (MCPIQ) , Bank of America (BAC) , Boeing (BA) , American Express (AXP) , Aurinia Pharmaceuticals (AUPH) , Actinium Pharmaceuticals (ATNM) , Advanced Micro Devices (AMD) , Alnylam Pharmaceuticals (ALNY) and Achaogen (AKAO) .

How do I buy shares of Affymax?

Shares of AFFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:AFFY

Affymax (AFFY) Stock Price, News & Analysis

→ Special FREE offer on stock hotsheets (From DTI) (Ad)

Free AFFY Stock Alerts

$0.0007

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.0007
▼
$0.0007
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.04

Volume: 200 shs
Average Volume: 23,861 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Short Interest

Get Affymax alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Affymax Stock (OTCMKTS:AFFY)

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

AFFY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AFFY Stock News Headlines

April 4, 2024 | finance.yahoo.com

Full Glass Wine Co. Secures $14 Million Funding; Acquires Leading DTC Wine Subscription Brand, Bright Cellars

February 27, 2024 | finance.yahoo.com

Nested Therapeutics Strengthens Board of Directors with Appointment of New Chair and Directors

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

February 23, 2024 | benzinga.com

Affymax Stock (OTC:AFFY), Short Interest Report

September 25, 2023 | finance.yahoo.com

Jasper Therapeutics Appoints Herb Cross as Chief Financial Officer

September 18, 2023 | markets.businessinsider.com

AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors

June 7, 2023 | thestreet.com

4 Biotech Stocks Under $5 to Watch

May 15, 2023 | thestreet.com

10 Biotech Stocks on Clinical Trials Watch

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

January 19, 2023 | bizjournals.com

Why a UCSF vice chancellor is returning to the biotech industry

January 18, 2023 | marketwatch.com

Hinge Bio Expands Senior Management Team to Drive GEM-DIMER(TM) Programs to Clinical Development

January 18, 2023 | nz.finance.yahoo.com

Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development

September 14, 2022 | finanznachrichten.de

Turn Biotechnologies, Inc.: Turn Biotechnologies launches eTurna delivery platform designed specifically to enable nucleic acid therapeutics

August 28, 2022 | reuters.com

AFFY.PK - Affymax, Inc. | Stock Price & Latest News | Reuters

August 25, 2022 | finance.yahoo.com

Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel

August 3, 2022 | investing.com

Esso Thailand PCL F (ESSOf)

August 3, 2022 | investing.com

Dialog Group Bhd (DIAL)

July 30, 2022 | investing.com

DPS Resources Bhd (DPSS)

April 27, 2022 | marketwatch.com

Renal Disease Treatment Market Size with New Growth Prospect By Top Key Players | Impact of COVID-19 Pandemic

March 27, 2022 | marketwatch.com

Renal Disease Treatment Market Scope with New Growth Prospect By Top Key Players | Impact of COVID-19 Pandemic

September 2, 2021 | ca.finance.yahoo.com

Arcutis Announces Appointment of Keith Leonard to Board of Directors

See More Headlines

Receive AFFY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affymax and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: Biotechnology
Current Symbol: OTCMKTS:AFFY
CUSIP: 00826A10
CIK: 1158223
Web: www.affymax.com
Phone: (650) 812-8700
Fax: 650-424-0832
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 5.90

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Mark G. Thompson (Age 62)
CFO & Secretary
Comp: $97.49k
Mr. Jonathan M. Couchman (Age 54)
CEO, President & Director
Dr. Tracy J. Dunn Ph.D. (Age 61)
J.D., Vice President of Intellectual Property & Legal Affairs

Key Competitors

View All Competitors

AFFY Stock Analysis - Frequently Asked Questions

How have AFFY shares performed in 2024?: Affymax's stock was trading at $0.0006 at the beginning of the year. Since then, AFFY stock has increased by 16.7% and is now trading at $0.0007.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Affymax own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Affymax investors own include Golden Peak Minerals Inc.. (GRM), (MCPIQ) (MCPIQ), Bank of America (BAC), Boeing (BA), American Express (AXP), Aurinia Pharmaceuticals (AUPH), Actinium Pharmaceuticals (ATNM), Advanced Micro Devices (AMD), Alnylam Pharmaceuticals (ALNY) and Achaogen (AKAO).
How do I buy shares of Affymax?: Shares of AFFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AFFY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Affymax (AFFY) Stock Price, News & Analysis

About Affymax Stock (OTCMKTS:AFFY)

AFFY Stock Price History

AFFY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

AFFY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info